IVD
Next-Generation Sequencing (NGS)
Precision Medicine
Marketa Svobodova
Marketa Svobodova is IVD Regulatory Director for Precision Medicine at MDx CRO with over 10 years of experience in molecular diagnostics, regulatory affairs, and in vitro diagnostic (IVD) development. She specialises in precision medicine, Next-Generation Sequencing (NGS)-based diagnostics, technical documentation, and performance evaluation strategies under the IVDR. Throughout her career, Marketa has supported the development of innovative diagnostic technologies for oncology, infectious diseases, food safety, and genetic testing, helping manufacturers bring compliant, high-quality IVDs to market.
Latest Articles
Blog & Insights
Blog & Insights
IVDR for NGS Assays: 7 Key Compliance Challenges (and How to Solve Them)
Last Updated: 2026-08-12
Read more